[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "786 977 3380", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.703, "open": 0.66, "dayLow": 0.66, "dayHigh": 0.73, "regularMarketPreviousClose": 0.703, "regularMarketOpen": 0.66, "regularMarketDayLow": 0.66, "regularMarketDayHigh": 0.73, "payoutRatio": 0.0, "beta": 0.29, "forwardPE": -1.0111268, "volume": 112652, "regularMarketVolume": 112652, "averageVolume": 124180, "averageVolume10days": 94060, "averageDailyVolume10Day": 94060, "bid": 0.6599, "ask": 0.738, "bidSize": 1, "askSize": 1, "marketCap": 5343744, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 3.85, "allTimeHigh": 170.0, "allTimeLow": 0.65, "fiftyDayAverage": 0.7501, "twoHundredDayAverage": 0.988355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1873308, "profitMargins": 0.0, "floatShares": 7331253, "sharesOutstanding": 7443577, "sharesShort": 38606, "sharesShortPriorMonth": 21917, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0052, "heldPercentInsiders": 0.01509, "heldPercentInstitutions": 0.12714, "shortRatio": 0.4, "shortPercentOfFloat": 0.0053, "impliedSharesOutstanding": 7443578, "bookValue": 10.603, "priceToBook": 0.067707255, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -13456890, "trailingEps": -7.13, "forwardEps": -0.71, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": 0.143, "52WeekChange": -0.7803125, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.7179, "recommendationKey": "none", "totalCash": 7217052, "totalCashPerShare": 0.97, "ebitda": -13087101, "totalDebt": 0, "quickRatio": 4.155, "currentRatio": 4.972, "returnOnAssets": -0.49517, "returnOnEquity": -0.85839, "freeCashflow": -7916161, "operatingCashflow": -12488130, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": 1.6715454, "postMarketPrice": 0.7299, "postMarketChange": 0.012000024, "regularMarketChange": 0.0149, "regularMarketDayRange": "0.66 - 0.73", "fullExchangeName": "NasdaqCM", "regularMarketChangePercent": 2.11948, "regularMarketPrice": 0.7179, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1763167998, "regularMarketTime": 1763154001, "marketState": "CLOSED", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "averageDailyVolume3Month": 124180, "fiftyTwoWeekLowChange": 0.0679, "fiftyTwoWeekLowChangePercent": 0.10446154, "fiftyTwoWeekRange": "0.65 - 3.85", "fiftyTwoWeekHighChange": -3.1320999, "fiftyTwoWeekHighChangePercent": -0.8135325, "fiftyTwoWeekChangePercent": -78.03125, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755374400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.13, "epsForward": -0.71, "fiftyDayAverageChange": -0.03220004, "fiftyDayAverageChangePercent": -0.04292766, "twoHundredDayAverageChange": -0.270455, "twoHundredDayAverageChangePercent": -0.27364156, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]